Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
44 th Annual Meeting<br />
and ToxExpo<br />
<strong>Program</strong> Description<br />
#1774 ESTROGEN INFLUENCES THE GROWTH OF<br />
CELLS THROUGH MODULATING THE<br />
INTRACELLULAR REDOX STATE. Q. Felty and<br />
D. Roy. Environmental & Occupational Health, Florida<br />
International University, Miami, FL.<br />
#1775 THE EFFECT OF POLYCHLORINATED<br />
BIPHENYLS (PCBs) ON THYROID HORMONE<br />
RECEPTOR (TR) AND CO-REGULATOR<br />
INTERACTIONS ON DNA. S. You 1 , K. Gauger 1 and<br />
R. Zoeller 2,1 . 1 Molecular & Cellular Biology <strong>Program</strong>,<br />
University <strong>of</strong> Massachusetts, Amherst, MA and<br />
2 Biology, University <strong>of</strong> Massachusetts, Amherst, MA.<br />
Wednesday Afternoon, March 9<br />
1:30 PM to 4:30 PM<br />
Exhibit Hall<br />
POSTER SESSION: PHARMACEUTICALS-METABOLIC/CANCER<br />
Chairperson(s): Thomas Mably, Bristol Meyers Squibb Co, Evansville, IN.<br />
Displayed: 1:30 PM–4:30 PM<br />
Attended: 1:30 PM–3:00 PM<br />
#1776 GENETIC TOXICOLOGY AND BONE MARROW<br />
CYTOTOXICITY STUDIES OF THE<br />
CORTICOTROPIN-RELEASING HORMONE<br />
(CRH) RECEPTOR ANTAGONIST,<br />
ANTALARMIN. P. T. Curry 1 , M. Nagabhushan 1 , D. L.<br />
McCormick 1 , R. E. Parchment 2 , K. Calis 3 , P. W. Gold 3 ,<br />
G. Cizza 3 , D. Charney 3 , E. R. Glaze 4 and J. E.<br />
Tomaszewski 4 . 1 IIT Research Institute, Chicago, IL,<br />
2 SciTech Development LLC, Grosse Pointe, MI,<br />
3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />
4 National Cancer Institute, Bethesda, MD.<br />
#1777 SUBCHRONIC ORAL TOXICITY OF THE<br />
CORTICOTROPIN-RELEASING HORMONE<br />
(CRH) RECEPTOR ANTAGONIST,<br />
ANTALARMIN, IN DOGS. W. D. Johnson 1 , J.<br />
Harder 1 , D. L. McCormick 1 , R. L. Morrissey 2 , K.<br />
Calis 3 , P. W. Gold 3 , G. Cizza 3 , D. Charney 3 , E. R.<br />
Glaze 4 and J. E. Tomaszewski 4 . 1 IIT Research Institute,<br />
Chicago, IL, 2 Pathology Associates, Chicago, IL,<br />
3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />
4 National Cancer Institute, Bethesda, MD.<br />
#1778 SUBCHRONIC ORAL TOXICITY OF THE<br />
CORTICOTROPIN-RELEASING HORMONE<br />
(CRH) RECEPTOR ANTAGONIST,<br />
ANTALARMIN, IN RATS. T. L. Horn 1 , W. D.<br />
Johnson 1 , D. L. McCormick 1 , R. L. Morrissey 2 , K.<br />
Calis 3 , P. W. Gold 3 , G. Cizza 3 , D. Charney 3 , E. R.<br />
Glaze 4 and J. E. Tomaszewski 4 . 1 IIT Research Institute,<br />
Chicago, IL, 2 Pathology Associates, Chicago, IL,<br />
3 National Institute <strong>of</strong> Mental Health, Bethesda, MD and<br />
4 National Cancer Institute, Bethesda, MD.<br />
#1780 REPEAT DOSE TOXICITY STUDIES IN RATS<br />
AND DOGS WITH TH0318, A DPP IV-RESISTANT<br />
ANALOG OF NATURAL GLP-1. S. Fennell 1 , H.<br />
Loughrey 1 , M. Garino 1 , S. Abdullah 1 , M. Stilianesis 2 ,<br />
K. Arjah 2 , B. Vu 2 and E. Ferdinandi 1 .<br />
1 Theratechnologies, Inc., Saint Laurent (Montreal), QC,<br />
Canada and 2 CTBR Bio-Research Inc., Senneville, QC,<br />
Canada. Sponsor: C. Banks.<br />
#1781 CARCINOGENICITY EVALUATION OF<br />
ATAZANAVIR IN MICE. T. A. Mably 1 , T. P.<br />
Sanderson 1 , C. D. Houle 2 , B. E. Schilling 1 and M. A.<br />
Dominick 1 . 1 Drug Safety Evaluation, Bristol-Myers<br />
Squibb Co., Mt.Vernon, IN and 2 Experimental<br />
Pathology Laboratories, Inc., Research Triangle Park,<br />
NC.<br />
#1782 MULTIPLE DOSE TOXICITY STUDY OF<br />
IMEXON IN FISCHER 344 RATS. Y. Chen 1 , E.<br />
Glaze 2 , J. Tomaszewski 2 , R. Morrissey 3 and A.<br />
Lyubimov 1 . 1 <strong>Toxicology</strong> Research Laboratory,<br />
University <strong>of</strong> Illinois at Chicago, Chicago, IL, 2 Division<br />
<strong>of</strong> Cancer Treatment and Diagnosis, National Cancer<br />
Institute, Bethesda, MD and 3 Pathology Associates<br />
Division, Charles River Laboratories, Chicago, IL.<br />
#1783 SEQUENCE DEPENDENT ANTAGONISM<br />
BETWEEN RALOXIFENE, 5-FLUOROURACIL<br />
AND PEMETREXED. E. Fryar 1 , D. H. Jillian 1 , S. M.<br />
William 2 and B. Donnell 1 . 1 Pharmacology, Howard<br />
University, Washington, DC and 2 Biochemistry, Howard<br />
University, Washington, DC.<br />
#1784 UTILIZATION OF MULTIPLE ENDPOINTS TO<br />
INVESTIGATE DIFFERENTIAL TOXICITY<br />
PRODUCED BY TOPOISOMERASE II<br />
INHIBITORS, DOXORUBICIN AND ETOPOSIDE.<br />
R. T. Dunn, E. S. Galambos, L. Healy, R. Morgan, J.<br />
Yamada, H. Hamadeh, A. Kwok, M. E. Cosenza and C.<br />
Afshari. <strong>Toxicology</strong>, Amgen Inc., Thousand Oaks, CA.<br />
#1785 ORAL TOXICITY STUDY OF A RETINOIC ACID<br />
ANALOGUE, 9-CIS-UAB-30, IN RATS. R.<br />
Krishnaraj 1 , A. Lyubimov 1 , C. Detrisac 2 , I.<br />
Kapetanovic 3 , J. Crowell 3 , W. Brouillette 4 and D.<br />
Muccio 4 . 1 Pharmacology, University <strong>of</strong> Illinois at<br />
Chicago, Chciago, IL, 2 Pathology Associates, Chciago,<br />
IL, 3 National Cancer Institute, Bethesda, MD and<br />
4 Chemistry, University <strong>of</strong> Alabama at Birmingham,<br />
Birmingham, AL.<br />
WEDNESDAY<br />
#1779 CYPROHEPTADINE AND CYCLIZINE INHIBIT<br />
INSULIN SECRETION IN RIN5F CELLS BY<br />
INHIBITING CALCIUM CHANNELS. M. Otieno 1 , N.<br />
Bavuso 1 , A. Katein 1 , T. Kelly 1 , J. Milano 1 and F.<br />
Pognan 2 . 1 Safety Assessment US, AstraZeneca<br />
Pharmaceuticals, Wilmington, DE and 2 Safety<br />
Assessment UK, AstraZeneca Pharmaceuticals, Alderly<br />
Park, United Kingdom.<br />
up-to-date information at www.toxicology.org 185